Drugs

What is Empagliflozin? Empagliflozin is an oral medication used in the management of type 2 diabetes mellitus. It belongs to a class of medications called sodium-glucose cotransporter-2 (SGLT-2) inhibitors, which work by inhibiting the reabsorption of glucose in the kidneys, thereby increasing the excretion of glucose in the urine and lowering blood glucose levels. Empagliflozin has also been shown to have beneficial effects on cardiovascular outcomes in patients with heart failure or established atherosclerotic cardiovascular disease....

What is Empagliflozin-linagliptin? Xultophy is an antidiabetic fixed-dose combination of empagliflozin (a sodium-glucose cotransporter 2 inhibitor) and linagliptin (a dipeptidyl peptidase-4 inhibitor). It works by reducing glucose reabsorption in the kidneys and increasing insulin secretion, thereby lowering blood glucose levels. Empagliflozin helps to remove excess glucose from the urine, while linagliptin enhances insulin production. The combination is used as an adjunct to diet and exercise for the treatment of type 2 diabetes mellitus....

What is Empagliflozin-liraglutide? Empagliflozin-liraglutide, also known as Mounjaro or Ozempemix (in combination), is an injectable medication that combines the glucagon-like peptide-1 receptor agonist liraglutide with the sodium-glucose cotransporter 2 inhibitor empagliflozin. It works by inhibiting glucose reabsorption in the kidneys and stimulating insulin secretion, thereby lowering blood sugar levels. This combination therapy is used to treat type 2 diabetes mellitus and manage glycemic control. What is Empagliflozin-liraglutide used for? Empagliflozin-liraglutide, also known as Mounjaro-Saxenda or Xultophy in some countries, is a fixed-dose combination of two well-established antidiabetic medications....

What is Empagliflozin-metformin? Empagliflozin-Metformin is an oral antidiabetic combination medication, specifically designed for the treatment of type 2 diabetes. It combines empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor that helps reduce blood sugar levels by preventing glucose reabsorption in the kidneys, with metformin, a biguanide that works by decreasing glucose production in the liver and improving insulin sensitivity. This dual-action combination is intended to lower fasting plasma glucose, HbA1c, and improve glycemic control while also offering potential cardiovascular benefits....

What is Enalapril? Enalapril is an angiotensin-converting enzyme (ACE) inhibitor used in the management of hypertension and congestive heart failure. It works by relaxing blood vessels, allowing blood to flow more easily and reducing pressure on the heart. By inhibiting the conversion of angiotensin I to angiotensin II, enalapril also has a natriuretic effect, promoting sodium excretion in the urine and contributing to its blood pressure-lowering effects. What is Enalapril used for?...